Gilead Sciences to Present at Two Upcoming Investor Conferences

- 17thAnnual BIO CEO & Investor Conference -

- 2015 Leerink Global Healthcare Conference -

- Webcasts Available Through Gilead Corporate Website -

BIO CEO & Investor Conference 2015
Leerink Global Healthcare Conference 2015

FOSTER CITY, Calif.--()--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from two upcoming investor conferences: the 17th Annual BIO CEO & Investor Conference and the 2015 Leerink Global Healthcare Conference, both taking place in New York.

John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will provide an overview of the company at the BIO CEO conference on Tuesday, February 10 at 10:00 a.m. Eastern Time (ET) and the Leerink conference on Wednesday, February 11 at 10:15 a.m. ET.

The live webcast of the call can be accessed at the company’s Investors page at www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the call to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Contacts

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936 (Investor Relations)

Contacts

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936 (Investor Relations)